{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:08:42Z","timestamp":1793650122052,"version":"4.5.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cytogfr.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:30:55Z","timestamp":1766122255000},"page":"113-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The cytokine\u2013skin barrier axis in health and disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Maria Victoria","family":"Souto-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabete Cristina Iseke","family":"Bispo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakaly Natiely","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Zonari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Saldanha-Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-0523","authenticated-orcid":false,"given":"Juliana Lott","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2025.12.009_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12913","article-title":"\u03b3\u03b4 T cells and inflammatory skin diseases","volume":"298","author":"Jee","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib3","unstructured":"[No title]. \u3008https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB156\/B156_(24)-en.pdf\u3009."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.70169","article-title":"OS-01 peptide topical formulation improves skin barrier function and reduces systemic inflammation markers: a pilot 12-week clinical trial","volume":"24","author":"Zonari","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-19683-6_1","article-title":"Sensing the environment: regulation of local and global homeostasis by the skin\u2019s neuroendocrine system","volume":"212","author":"Slominski","year":"2012","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2017.10.002","article-title":"Barrier dysfunction in the skin allergy","volume":"67","author":"Egawa","year":"2018","journal-title":"Allergol. Int."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4168\/aair.2024.16.5.445","article-title":"Skin lipid barrier: structure, function and metabolism","volume":"16","author":"Berdyshev","year":"2024","journal-title":"Allergy Asthma Immunol. Res"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/intimm\/dxy088","article-title":"Eavesdropping on the conversation between immune cells and the skin epithelium","volume":"31","author":"Bukhari","year":"2019","journal-title":"Int Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239598","article-title":"Input\/output cytokines\u2019 in epidermal keratinocytes and the involvement in inflammatory skin diseases","volume":"14","author":"Morizane","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9527","article-title":"A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity","volume":"10","author":"Shipman","year":"2018","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fimmu.2016.00210","article-title":"Chronic Inflammation and \u03b3\u03b4 T Cells","volume":"7","author":"Fay","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mi.2007.9","article-title":"Terminology: nomenclature of mucosa-associated lymphoid tissue","volume":"1","author":"Brandtzaeg","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000534136","article-title":"The skin barrier and moisturization: function, disruption, and mechanisms of repair","volume":"36","author":"Rajkumar","year":"2023","journal-title":"Ski. Pharm. Physiol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat6280","article-title":"Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury","volume":"363","author":"Harrison","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib18","article-title":"Macrophages induce AKT\/\u03b2-catenin-dependent Lgr5 stem cell activation and hair follicle regeneration through TNF","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib19","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1074\/jbc.M508608200","article-title":"Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages","volume":"281","author":"Qasimi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.558341","article-title":"SOCS proteins participate in the regulation of innate immune response caused by viruses","volume":"11","author":"Huang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.it.2021.04.007","article-title":"Tissue-resident macrophages: guardians of organ homeostasis","volume":"42","author":"Nobs","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061323","article-title":"Hallmarks of aging in macrophages: consequences to skin inflammaging","volume":"10","author":"Guimar\u00e3es","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1556\/1886.2017.00009","article-title":"Fibroblasts: the unknown sentinels eliciting immune responses against microorganisms","volume":"7","author":"Bautista-Hern\u00e1ndez","year":"2017","journal-title":"J. Eur. J. Microbiol. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib24","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/s41467-023-37798-x","article-title":"Tenascin C papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib25","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145185","article-title":"Particulate matter causes skin barrier dysfunction","volume":"6","author":"Kim","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1523-1747.2003.12365.x","article-title":"pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity\/cohesion","volume":"121","author":"Hachem","year":"2003","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.13152","article-title":"Skin barrier immunity and ageing","volume":"160","author":"Chambers","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810152","article-title":"Pathogenesis of inflammation in skin disease: from molecular mechanisms to pathology","volume":"25","author":"Shirley","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib30","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jaci.2016.07.003","article-title":"Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes","volume":"138","author":"Xian","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/exd.13943","article-title":"Particulate matter induces pro-inflammatory cytokines via phosphorylation of p38 MAPK possibly leading to dermal inflammaging","volume":"28","author":"Kim","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jaad.2014.12.010","article-title":"Incidence and risk of xerosis with targeted anticancer therapies","volume":"72","author":"Valentine","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jaad.2024.08.044","article-title":"Clinical consequences of age-related skin barrier dysfunction-Part I: Structural, molecular, and physiologic changes with cutaneous aging","volume":"93","author":"Wahhab","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-016-0176-y","article-title":"Skin disorders in diabetes mellitus: an epidemiology and physiopathology review","volume":"8","author":"de Macedo","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib35","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/ndt\/gfh480","article-title":"Uraemic xerosis","volume":"19","author":"Szepietowski","year":"2004","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02847","article-title":"Emerging Topical and Systemic JAK Inhibitors in Dermatology","volume":"10","author":"Solimani","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jaci.2023.07.010","article-title":"The role of Janus kinase signaling in the pathology of atopic dermatitis","volume":"152","author":"Guttman-Yassky","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib38","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.1801211","article-title":"Skin-Associated B Cells in Health and Inflammation","volume":"202","author":"Debes","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib39","article-title":"Unraveling the biological potential of skin fibroblast: responses to TNF-\u03b1, highlighting intracellular signaling pathways and secretome","volume":"276","year":"2025","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4110\/in.2014.14.1.14","article-title":"NF-\u03baB Activation in T Helper 17 Cell Differentiation","volume":"14","author":"Park","year":"2014","journal-title":"Immune Netw."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib41","first-page":"469","article-title":"Curcumin attenuates the expression of IL-1\u03b2, IL-6, and TNF-\u03b1 as well as cyclin E in TNF-\u03b1-treated HaCaT cells; NF-\u03baB and MAPKs as potential upstream targets","volume":"19","author":"Cho","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1600-0625.2007.00672.x","article-title":"Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases","volume":"17","author":"Kjellerup","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121671","article-title":"The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds","volume":"12","author":"Roy","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031693","article-title":"Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential","volume":"23","author":"Karagianni","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib45","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jid.2024.02.012","article-title":"S100A9 Exacerbates the Inflammation in Rosacea through Toll-Like Receptor 4\/MyD88\/NF-\u03baB Signaling Pathway","volume":"144","author":"Le","year":"2024","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109011","article-title":"Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-\u03baB activation in keratinocytes","volume":"116","author":"Chen","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ptr.8071","article-title":"Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK\/ERK and NF-\u03baB signaling pathways","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother. Res"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib48","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","article-title":"The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin","volume":"8","author":"Weaver","year":"2013","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228790","article-title":"The Immune Functions of Keratinocytes in Skin Wound Healing","volume":"21","author":"Piipponen","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","article-title":"Identification of a key pathway required for the sterile inflammatory response triggered by dying cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155890","article-title":"The IL-1 cytokine family as custodians of barrier immunity","volume":"154","author":"Matarazzo","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169479","article-title":"IL-1 Family cytokines in inflammatory dermatoses: pathogenetic role and potential therapeutic implications","volume":"23","author":"Iznardo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib54","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jid.2023.11.004","article-title":"Emerging Role of the IL-36\/IL-36R axis in multiple inflammatory skin diseases","volume":"144","author":"Ahmad","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib55","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900586","article-title":"Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice","volume":"3","author":"Hern\u00e1ndez-Santana","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib56","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jid.2019.08.444","article-title":"IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis","volume":"140","author":"Catapano","year":"2020","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5114\/ada.2022.119077","article-title":"Interleukins 20 and 8 - less widely known cytokines in psoriasis","volume":"40","author":"Kutwin","year":"2023","journal-title":"Post. Dermatol. Alergol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114399","article-title":"Unraveling the role of the IL-20 cytokine family in neurodegenerative diseases: Mechanisms and therapeutic insights","volume":"152","author":"Goleij","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib59","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101800R","article-title":"IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis","volume":"36","author":"Lu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155828","article-title":"Interleukin-8: an evolving chemokine","volume":"153","author":"Matsushima","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib62","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jid.2024.06.1280","article-title":"The central roles of keratinocytes in coordinating skin immunity","volume":"144","author":"Simmons","year":"2024","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib63","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s11739-023-03309-5","article-title":"Therapeutic inhibition of CXCR1\/2: where do we stand?","volume":"18","author":"Sitaru","year":"2023","journal-title":"Intern Emerg. Med"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and Keratinocytes in Psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib65","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.3390\/ijms26072989","article-title":"IL-17 ligand and receptor family members are differentially expressed by keratinocyte subpopulations and modulate their differentiation and inflammatory phenotype","volume":"26","author":"Palazzo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib66","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","article-title":"Keratinocyte-derived IL-17E contributes to inflammation in psoriasis","volume":"136","author":"Senra","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib67","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jid.2019.12.013","article-title":"IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytes","volume":"140","author":"Borowczyk","year":"2020","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JD9.0000000000000094","article-title":"The immune function of keratinocytes in anti-pathogen infection in the skin","volume":"3","author":"Wang","year":"2020","journal-title":"Int. J. Dermatol. Venereol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib69","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/ACI.0000000000000926","article-title":"The pathogenetic role of Th17 immune response in atopic dermatitis","volume":"23","author":"David","year":"2023","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8050101","article-title":"The Role of IL-6 in Skin fibrosis and cutaneous wound healing","volume":"8","author":"Johnson","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib73","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-013-0633-0","article-title":"TNF-\u03b1 signalling and inflammation: interactions between old acquaintances","volume":"62","author":"Zelov\u00e1","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib74","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.4049\/jimmunol.2000596","article-title":"The role of cutaneous Type I IFNs in autoimmune and autoinflammatory diseases","volume":"205","author":"Turnier","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cytogfr.2021.01.006","article-title":"Hallmarks of aging and immunosenescence: connecting the dots","volume":"59","author":"Rodrigues","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib76","article-title":"The regulation of inflammation by interferons and their STATs","volume":"2","author":"Rauch","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/exd.12076","article-title":"Evidence for a regulatory loop between IFN-\u03b3 and IL-33 in skin inflammation","volume":"22","author":"Seltmann","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib78","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib80","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib81","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN\u03bb) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib83","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.1916897117","article-title":"Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus","volume":"117","author":"Goel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib84","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1\u03b1 and IL-1\u03b2 recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib85","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib86","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/exd.13228","article-title":"IL-36\u03b3 has proinflammatory effects on human endothelial cells","volume":"26","author":"Bridgewood","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155935","article-title":"IL-1 family cytokines serve as \u2018activity recognition receptors\u2019 for aberrant protease activity indicative of danger","volume":"157","author":"Martin","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808012","article-title":"The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier","volume":"12","author":"Macleod","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib89","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","article-title":"The IL-20 subfamily of cytokines--from host defence to tissue homeostasis","volume":"14","author":"Rutz","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib90","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1600-0625.2006.00516.x","article-title":"Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs","volume":"15","author":"Kunz","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib91","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/eji.200939687","article-title":"The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis","volume":"39","author":"Wolk","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib93","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib94","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-0716-1130-2_5","article-title":"Transition from TNF-Induced Inflammation to Death Signaling","volume":"2248","author":"Choksi","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib95","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/706825","article-title":"The role of genetic variation near interferon-kappa in systemic lupus erythematosus","volume":"2010","author":"Harley","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib96","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jid.2016.09.008","article-title":"Lupus Skin Is Primed for IL-6 Inflammatory Responses through a Keratinocyte-Mediated Autocrine Type I Interferon Loop","volume":"137","author":"Stannard","year":"2017","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2362.2011.02557.x","article-title":"Profiling the expression of interleukin (IL)-28 and IL-28 receptor \u03b1 in systemic lupus erythematosus patients","volume":"42","author":"Lin","year":"2012","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib98","first-page":"18","article-title":"Skin - a vast organ with immunological function (Review)","volume":"20","author":"Aida Maranduca","year":"2020","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910841","article-title":"Skin Barrier Dysregulation in Psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib100","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jocd.16339","article-title":"Oral tranexamic acid treats papulopustular rosacea by improving the skin barrier","volume":"23","author":"Xu","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib101","doi-asserted-by":"crossref","first-page":"R531","DOI":"10.1016\/S0960-9822(01)00312-8","article-title":"Cytokines: IL-20 - a new effector in skin inflammation","volume":"11","author":"Rich","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib102","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J. Mol. Med (Berl. )"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib103","doi-asserted-by":"crossref","first-page":"1286344","DOI":"10.3389\/fimmu.2023.1286344","article-title":"Crosstalk: keratinocytes and immune cells in psoriasis","volume":"14","author":"Kamata","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib104","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1111\/jdv.19153","article-title":"IL-1\u03b1\/\u03b2 and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis","volume":"37","author":"Michaelidou","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib105","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/exd.14644","article-title":"IL-38 orchestrates proliferation and differentiation in human keratinocytes","volume":"31","author":"Mermoud","year":"2022","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154431","article-title":"The JAK\/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: a systematic review","volume":"11","author":"Tsiogka","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib107","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100749118","article-title":"Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib108","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"Howell","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib109","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/exd.14749","article-title":"Keratinocytes activated by IL-4\/IL-13 express IL-2R\u03b3 with consequences on epidermal barrier function","volume":"32","author":"Progneaux","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib110","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jid.2021.04.002","article-title":"Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes","volume":"141","author":"Dai","year":"2021","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","article-title":"Interleukin-33 in atopic dermatitis","volume":"96","author":"Imai","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib112","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2011.10.042","article-title":"IL-31 regulates differentiation and filaggrin expression in human organotypic skin models","volume":"129","author":"Cornelissen","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib113","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.3390\/ijms14046720","article-title":"Cytokines and the skin barrier","volume":"14","author":"H\u00e4nel","year":"2013","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110352","article-title":"IL-17 in skin infections and homeostasis","volume":"267","author":"Garc\u00eda-Pati\u00f1o","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174070","article-title":"Antagonistic Effects of IL-4 on IL-17A-mediated enhancement of epidermal tight junction function","volume":"20","author":"Brewer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0625.2011.01412.x","article-title":"IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion","volume":"21","author":"Gutowska-Owsiak","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib117","doi-asserted-by":"crossref","first-page":"E8277","DOI":"10.1073\/pnas.1618300114","article-title":"Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency","volume":"113","author":"L\u00e9vy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib118","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1172\/JCI70064","article-title":"Dendritic epidermal T cells regulate skin antimicrobial barrier function","volume":"123","author":"MacLeod","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib119","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51188","article-title":"Neonatal-derived IL-17 producing dermal \u03b3\u03b4 T cells are required to prevent spontaneous atopic dermatitis","volume":"9","author":"Spidale","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib120","doi-asserted-by":"crossref","first-page":"17446","DOI":"10.1038\/s41598-017-17782-4","article-title":"Epidermal cornification is preceded by the expression of a keratinocyte-specific set of pyroptosis-related genes","volume":"7","author":"Lachner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib121","article-title":"The Skin and Inflamm-Aging","volume":"12","author":"Agrawal","year":"2023","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib122","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaci.2016.06.002","article-title":"Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march","volume":"138","author":"Egawa","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib123","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bjd.16734","article-title":"Epithelial barrier dysfunctions in atopic dermatitis: a skin\u2013gut\u2013lung model linking microbiome alteration and immune dysregulation","volume":"179","author":"Zhu","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib124","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.3390\/ijms21082867","article-title":"Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib125","article-title":"Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib126","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib127","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-14-527","article-title":"Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients","volume":"14","author":"Swindell","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib128","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib129","first-page":"735","article-title":"Differential expression of cyclin D1, Ki\u201167, pRb, and p53 in psoriatic skin lesions and normal skin","volume":"17","author":"Kim","year":"2018","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib130","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib131","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12026-025-09606-9","article-title":"Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract","volume":"73","author":"Meng","year":"2025","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib132","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2015.06.029","article-title":"Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes","volume":"137","author":"Schmitt","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib133","article-title":"Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib134","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-26163-3_1","article-title":"Immune responses at host barriers and their importance in systemic autoimmune diseases","volume":"1408","author":"Schinnerling","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib135","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.18632\/aging.102946","article-title":"Aging-associated alterations in epidermal function and their clinical significance","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib136","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jid.2017.01.007","article-title":"Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines","volume":"137","author":"Hu","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib137","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/jdv.15540","article-title":"Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study","volume":"33","author":"Ye","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13148-020-00899-1","article-title":"Highly accurate skin-specific methylome analysis algorithm as a platform to screen and validate therapeutics for healthy aging","volume":"12","author":"Boroni","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib139","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41514-024-00140-w","article-title":"Author Correction: Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models","volume":"10","author":"Zonari","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib141","article-title":"Senescence as a molecular target in skin aging and disease","volume":"105","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.009_bib142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ijd.17790","article-title":"Restoring Skin Hydration and Barrier Function: Mechanistic Insights Into Basic Emollients for Xerosis Cutis","volume":"64","author":"Fluhr","year":"2025","journal-title":"Int J. Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib143","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12692","article-title":"Short- and long-term effects of two emollients on itching and skin restoration in xerotic eczema","volume":"31","author":"Simon","year":"2018","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178346","article-title":"The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice","volume":"26","author":"Ali","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib146","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212521","article-title":"Atopic dermatitis: a review of topical nonsteroid therapy","volume":"7","author":"Papier","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib147","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jamadermatol.2024.2517","article-title":"Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis","volume":"160","author":"Boesjes","year":"2024","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib148","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Le Floc\u2019h","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib149","article-title":"Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial","volume":"33","author":"Carucci","year":"2022","journal-title":"Pedia Allergy Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030557","article-title":"Topical Probiotics: More Than a Skin Deep","volume":"14","author":"Habeebuddin","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1137275","article-title":"for the treatment and prevention of atopic dermatitis: Clinical and experimental evidence","volume":"13","author":"Xie","year":"2023","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib152","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib153","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.biotechadv.2018.08.005","article-title":"Breaking the frontiers of cosmetology with antimicrobial peptides","volume":"36","author":"Alencar-Silva","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/cells13100813","article-title":"Senotherapeutic Peptide 14 Suppresses Th1 and M1 Human T Cell and Monocyte Subsets In Vitro","volume":"13","author":"Alencar-Silva","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/cosmetics11060223","article-title":"Skin barrier-improving and skin-soothing effects of autophagy-activating peptide on sensitive skin","volume":"11","author":"Eun","year":"2024","journal-title":"Cosmetics"},{"key":"10.1016\/j.cytogfr.2025.12.009_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207607","article-title":"Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib157","article-title":"The antimicrobial peptide amp-ibp5 suppresses dermatitis-like lesions in a mouse model of atopic dermatitis through the low-density lipoprotein receptor-related protein-1 receptor","volume":"24","author":"Nguyen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2025.12.009_bib158","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/term.2953","article-title":"IDR-1018 induces cell proliferation, migration, and reparative gene expression in 2D culture and 3D human skin equivalents","volume":"13","author":"Alencar-Silva","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.009_bib159","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ics.12926","article-title":"A novel Ca2+ double cone vector system to treat compromised skin","volume":"46","author":"Baumann","year":"2024","journal-title":"Int. J. Cosmet. Sci."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:13:09Z","timestamp":1773933189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":159,"alternative-id":["S1359610125001674"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.12.009","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytokine\u2013skin barrier axis in health and disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}